Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
92.04 CHF | +1.65% | +4.55% | +8.37% |
03:43pm | Novartis Gets FDA Breakthrough Therapy Designation for Scemblix | DJ |
May. 06 | NOVARTIS AG : UBS maintains a Buy rating | ZD |
Filters
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG